Edward Freedman

Ed has more than 25 years of leadership experience directing finance, legal and operations activities in companies across multiple industries. Ed has served as COO of Pandion Therapeutics as well as in CFO roles at Dyno Therapeutics, Faze Medicines, Kymera Therapeutics, Mana Therapeutics, KSQ Therapeutics, XTuit Pharmaceuticals, Oasys Water and Ensemble Therapeutics. Ed also served as General Counsel of Flagship Ventures (now Flagship Pioneering) and started his legal career at Testa, Hurwitz & Thibeault, LLP. Before going to law school, Ed was an accountant at Arthur Andersen & Co.

Ed earned his JD from Boston College Law School and his BSBA in Accounting from Boston University.